8-KRegulation FDExhibits & Filings

CME GROUP INC. 8-K Report, Regulation FD Disclosure (Dec 11, 2024)

Filed December 11, 2024For Securities:CME

Summary

CME Group Inc. (CME) has filed an 8-K report on December 11, 2024, to disclose recent communications regarding changes to its Clearing House collateral fee schedule and client pricing. These changes were communicated to Clearing Members via Advisory Notice 24-383 and to clients through Special Executive Report 9482 on December 10, 2024. While the specifics of the fee and pricing adjustments are not detailed within the 8-K itself, investors should note that these communications represent material updates to the company's operational and revenue-generating framework. The company has made these notices available on its website, signaling transparency regarding these important financial adjustments.

Key Highlights

  • 1CME Group announced changes to its Clearing House collateral fee schedule.
  • 2Pricing changes were communicated to clients.
  • 3The effective date of these communications was December 10, 2024.
  • 4Clearing Members were notified via Advisory Notice 24-383.
  • 5Clients were informed through Special Executive Report 9482.
  • 6The full notices are available on CME Group's website.
  • 7This filing primarily serves as a Regulation FD disclosure.

Frequently Asked Questions